Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

http://www.wikidata.org/entity/Q46818834

about

Biomarkers of Renal Disease and Progression in Patients with Diabetes Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells.Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy.Expanded network of inflammatory markers of atherogenesis: where are we now?Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy.The role of interleukin-18 in the metabolic syndrome.Inflammation in diabetic kidney disease Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome.A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease Serum interleukin-18 levels are associated with physical activity in Japanese men Inflammatory cytokines in diabetic nephropathy.Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients.Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis.Interleukin-18 Promoter Gene Polymorphisms are not Associated with Myocardial Infarction in Type 2 Diabetes in Slovenia Immune and inflammatory role in renal disease.Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes.Increased adipose tissue expression of TLR8 in obese individuals with or without type-2 diabetes: significance in metabolic inflammation.Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).An update on markers of carotid atherosclerosis in patients with Type 2 diabetes.Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review.Inflammation in diabetic nephropathy.Microinflammation in the pathogenesis of diabetic nephropathy.Diabetic nephropathy and inflammation.T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.The role of novel biomarkers in predicting diabetic nephropathy: a review.Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy.Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity.The NLRP3 inflammasome in kidney disease and autoimmunity.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis.Modeling the Causal Role of DNA Methylation in the Association Between Cigarette Smoking and Inflammation in African Americans: A 2-Step Epigenetic Mendelian Randomization Study.A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.Assessment of IL-18 Serum Level and Its Promoter Polymorphisms in the Saudi Coronary Artery Disease (CAD) Patients.Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis.

P2860

Q26799505-2AFB1C8C-758F-4CCD-891D-3E2C26E145B1 Q33273439-6D1ECB7E-EFF7-4783-9195-42927A905EDE Q33307444-C80A7F3F-2979-488E-B4FA-FD78191E7045 Q33603422-E68E9825-A96D-4B83-BF49-A89F7CF3819D Q33738532-722E3FAF-3CBC-486D-9D01-948512E889EE Q33772238-64C62776-3F59-460C-A35B-30582423F236 Q33804391-A2E20390-14BC-4DE2-B495-1B221B8F5696 Q34023543-3B302CCA-C8AD-42FA-B3E8-2404BD9A4522 Q34573680-887A2A65-3351-4224-98DB-E33F6723178C Q34595154-77D3B1BE-2214-419D-BE1D-607A43C98E0C Q35069621-1219D2C3-F5F1-4E03-A506-18DBD8F2E023 Q35133177-48C3EDE1-C2AB-49AE-9CA3-5D31A551B1AE Q35673446-53B9718C-451D-4570-AE64-A37684335D8E Q36740444-9144B0C4-5438-493B-9DAC-0C97A4A7E9F1 Q36970340-A3336FB9-0E5A-4948-A0AE-D35EADA86DDE Q37181582-87FCC853-47EE-4C89-B66B-E73A37692031 Q37243199-9AD0A9C6-7770-4E5A-82EA-CB4569C10F7C Q37313140-2FC07E9D-3ECC-4405-BB98-589BA453AE86 Q37487975-4DEAE9B2-8C45-49D7-87C2-5C1E99B6951B Q37597721-9F678203-C67A-46B5-AEAF-0470FD88BA88 Q37684606-ECB2DA2D-9BEA-480B-BEF5-940B23883664 Q37779311-EA36AEC7-1714-4E22-9B34-CBB13A679970 Q37780781-89E06623-74F2-4276-9D83-B347E79EAF43 Q37931336-E2F003F8-4D98-490A-98B2-2A7FC4FEC968 Q38042593-26536375-B123-4EF2-BDBC-162762E807B3 Q38213048-C3ACCE13-BA89-4716-A9C4-5586A71C687B Q38220820-74C0716F-D466-42D3-93FB-3B1830D9DE7D Q38430526-73C8A8E8-2B74-4717-958C-3DA5FA50D572 Q38598929-8F60B655-9278-475B-BD88-C183985A5546 Q38674772-A708BBFB-4FD7-4353-A0B4-A97AC964EE63 Q38784122-05A047B6-EB62-45ED-A617-B446649F756D Q38787339-09A4E4D0-3779-4A74-A55E-10C9BB0F4839 Q38936622-67FA71E1-FDEC-4EC1-81B0-2356172480DF Q39604870-04D6B86A-1C9C-40B3-A9BD-80E3862BDAFA Q47131367-427B784E-D29F-4F51-8A0E-5484EAF2D3A3 Q47391787-0B63F0F7-E4AE-4A16-8568-7F30CD7A15A6 Q48097780-93B3790C-8ED2-44E9-8882-0F51771E4B93 Q51213017-B1A45432-4E34-4CD9-BD84-1BF397AD6EAF Q51391705-E025F2C8-5549-4EF3-895E-1DAD32D6F058 Q52956251-887E76D1-3465-4E03-B59C-8C0731E83C3C

P2860

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

http://www.wikidata.org/entity/Q46818834

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@en

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@nl

type

label

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@en

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@nl

prefLabel

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@en

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@nl

P1433

Q46818834-96960EC2-3745-4A88-AE62-C1981393923D

P1476

Q46818834-3F32D824-8ACB-4A11-B655-DB13C960C103

P2093

Q46818834-3D5B298F-42EC-405E-AF7B-84E0E804AFEF

Q46818834-628390B3-665B-4DF0-AA7C-BC4166650659

Q46818834-64287433-1409-45BE-B563-74509F6C931A

Q46818834-64845C64-3864-4F28-815D-F6742D1574D0

Q46818834-7C532B7D-BB42-42CD-854B-74579AF14B61

Q46818834-C4D54927-BAEC-4983-8EF1-8C74F2EDEE47

Q46818834-CF75A7CA-B968-4957-B5AA-3E124EF0D418

Q46818834-E25C87F8-463A-4425-B396-09E6D8F31089

P304

Q46818834-CB54E3E0-89A8-42EE-8110-9A3904859482

P31

Q46818834-C905B763-65D5-472D-BA9D-79866A5A9321

P356

Q46818834-2ADA7488-8E96-42D5-A894-6B598F3F4697

P407

Q46818834-E6AE7D1E-2A74-445A-80BA-98B54E6FFD98

P433

Q46818834-E1B9E6C3-6C1D-4D80-97F2-5CE227F4EE8E

P478

Q46818834-60C3CB40-A38E-473A-8ED2-A4075A49F140

P577

Q46818834-CBCBDEDC-EA7C-4E7C-99B3-44ACB43FFBA5

P5875

Q46818834-205836FD-8309-4A83-910A-EAB2C48EF4D8

P698

Q46818834-F4252FCF-41BE-402C-B32C-C50FCF3B82BA

P921

Q46818834-1E11A776-8D0F-4BD5-94C3-9EA68A2F9B94

Q46818834-955C2DA1-002C-4AEB-A03D-7370D0A677B5

Q46818834-F5D96FB8-A87C-41D2-B294-D136383655CA

Q46818834-e0b0b193-4662-4333-a8e6-5642dc414817

P356

DIACARE.28.12.2890

P1433

P1476

Serum interleukin-18 levels ar ...... patients with type 2 diabetes.

@en

P2093

Akihiko Nakamura

http://www.w3.org/2001/XMLSchema#string

Hirofumi Makino

http://www.w3.org/2001/XMLSchema#string

Jun Wada

http://www.w3.org/2001/XMLSchema#string

Kenichi Shikata

http://www.w3.org/2001/XMLSchema#string

Makoto Hiramatsu

http://www.w3.org/2001/XMLSchema#string

Takuya Kitamura

http://www.w3.org/2001/XMLSchema#string

Tatsuaki Nakatou

http://www.w3.org/2001/XMLSchema#string

Tatsuya Itoshima

http://www.w3.org/2001/XMLSchema#string

P304

2890-2895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACARE.28.12.2890

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7461471

http://www.w3.org/2001/XMLSchema#string

P698

16306550

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

type-2 diabetes